ORTEXORTEX News
Tracking UAL? Get live short interest, options flow, and signals on ORTEX.Sign up free →
UA
Trader NoteUAL

UAL Options Hit Two-Year Defensive Peak After Q3 Results

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 19:32

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

United Airlines Holdings posted Q3 results this week and the options market responded with its most defensive positioning of the past year, even as short sellers moved in the opposite direction and trimmed exposure.

The clearest signal is in the put/call ratio. It jumped to 1.44 on October 20, more than two standard deviations above its 20-day average of 1.07, putting it near the 52-week high of 1.55. That is the kind of reading that reflects genuine demand for downside protection, not routine hedging. The shift is abrupt: the PCR spent most of September below 0.93, turned sharply higher after the October 13 preliminary results landed, and has stayed elevated. The stock fell 5.3% on the week to $97.77, a move that tracks closely with the peer group median. DAL dropped 3.7% and AAL fell 3.1% over the same period. The weaker ends of the airline group, JBLU and ULCC, shed 13% and 12% respectively, making UAL's loss look contained by comparison.

Short interest tells a different story from the options. Shorts covered sharply after the October 15 spike, when positions had jumped to 19.3 million shares or 5.96% of the free float following the preliminary results. By October 20, the short count had pulled back to 16.4 million shares, 5.1% of the free float, a decline of roughly 2.8% on the week. The borrow market offers no mechanism for a squeeze: availability has widened back to 5,032% of short interest, meaning there are more than 50 shares available to lend for every one currently borrowed. Cost to borrow is 0.39%, down 23% on the week. Shorts who wanted to press the position faced no friction; the fact that they chose not to is the more informative data point.

The Street remains broadly positive but has spent the past three weeks trimming targets. UBS cut its price target to $139 from $146 on October 16, maintaining its Buy rating. Susquehanna and Wells Fargo both lowered targets the prior week, to $150 and $160 respectively, while keeping positive ratings. The pattern across the recent changes is consistent: no firm has abandoned its bullish stance, but every one that moved cut the number. The mean price target across the analyst consensus is $152.74, a 56% premium to the current price. That gap is large, and it reflects a disagreement between the Street's fundamental view and where the stock is trading. The EV/EBITDA multiple has compressed to 5.7 from 6.3 over the past 30 days, while the PE sits at 8.5. UAL's analyst recommendation differential ranks in the 93rd percentile of the ORTEX universe, meaning it is one of the most positively skewed by analyst sentiment relative to peers. EPS surprise ranks in the 82nd percentile. The counter-weight is EPS momentum, which ranks in the 5th percentile over 30 days and the 11th over 90, indicating that estimate revisions have been moving the wrong way.

On the alt-data side, the Bureau of Transportation Statistics reported that US airline T-100 passenger volumes rose for three consecutive months through July, while on-time arrivals within 15 minutes fell for three consecutive months through August. Those two trends running in opposite directions describe a carrier system that is filling planes but struggling with punctuality. One other reading worth noting: retail attention on UAL, as measured by Wikipedia page views and ORTEX stock page visits, is running at a z-score of 4.5 against its own 90-day history, the highest in recent data. That level of retail attention typically follows a large price move rather than preceding one, and the 10% one-month decline in the stock explains most of it.

Insider activity through the end of August shows net selling of $27.6 million over the prior 90 days. The largest single transaction was President Brett Hart selling 30,108 shares at $120.72 on July 28 for $3.6 million, not under a 10b5-1 plan. The CFO sold 10,000 shares on August 3 under a pre-arranged 10b5-1 plan at $128.19. The discretionary nature of the Hart sale is worth noting, though the prices at which those sales were executed, in the $117 to $132 range, are well above the current $97.77 level.

The next scheduled earnings event is January 19, 2027. Between now and then, the question is whether the options premium priced into put hedges eases as the post-results uncertainty resolves, or whether it stays elevated as the Street continues to adjust its targets toward a stock that has now fallen 10% over the past month.

Stocks in this article

See the live data behind this article on ORTEX.

Open UAL on ORTEX →

How this article was generated

Generated
21 Oct 2026, 19:35
Data as of
21 Oct 2026, 19:32
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.